Medifast (MED) Management Shows Confidence In 2021 Targets - DA Davidson

DA Davidson analyst, Linda Bolton Weiser, reiterated her Buy rating on shares of Medifast (NYSE: MED) after spending time with the company's CEO and CFO who exhibited confidence in their targets of 50,000 Health Coaches and revenue of $1B in 2021.

The analyst estimates this could result in EPS of ~$9.50 stating "The new e-commerce platform was launched recently with minimal disruption, and the Asian expansion, along with a new Coach app, is planned to kick off on June 30th. We believe 1Q19 guidance could be conservative, and that sequential Health Coach growth could re-accelerate in 1Q19 or 2Q19.

No change to the price target of $250.

For an analyst ratings summary and ratings history on Medifast click here. For more ratings news on Medifast click here.

Shares of Medifast closed at $131.47 yesterday.

You May Also Be Interested In

• Alight Solutions (ALIT) Raised to $40 by DA Davidson on Reverse Stock Split
• Emkay Global Starts Vedanta Aluminium Metal (VAML:IN) at Buy (1)
• Elevance (ELV) PT Raised to $482 at Bernstein SocGen